Covid-19 and Immunity in Aging Populations — A New Research Agenda

New England Journal of Medicine logo

Despite billions of dollars poured into research and development efforts to control the SARS-CoV-2 virus, responses are delayed by our limited understanding of how to generate effective immunity, particularly in the elderly. If we can delineate principles of effective immunity in the elderly, we might also be able to develop new strategies for broader disease prevention and control in older populations. Covid-19 has highlighted the vulnerability of aging populations to…

How the U.S. should invest in public health before reopening the economy

Nail salon technician wearing PPE

Across the U.S., leaders are being urged to allow the reopening of businesses and ease the stay-at-home orders that have played a key role in reducing COVID-19 infection rates. However, doing so at this time is not only dangerous, it’s also potentially a catastrophic decision.  The current climate is rife with insecurity—job and housing insecurity, as well as inequities in available care and health coverage. Many Americans, whether unemployed, working…

Human Immunomics Initiative will decode immune system, speed new vaccines

Labtech uses micropipette

The Harvard T.H. Chan School of Public Health and the Human Vaccines Project announce the Human Immunomics Initiative, a joint project that aims to revolutionize the understanding of the human immune system and accelerate the creation of effective vaccines, diagnostics, and treatments. The Human Immunomics Initiative (HII) will bring together Harvard T.H. Chan School of Public Health experts in epidemiology, causal inference, immunology, and computational and systems biology with the…